New MRI contrast agent tested on big animals
Experiments in dogs, rabbits and monkeys show the efficacy and biocompatibility of a new MRI/MRA contrast agent in detecting stroke. This T1 MRI contrast agent based on ultrasmall iron oxide nanoparticles could become a possible alternative to clinically used gadolinium-based agents.
0 Comments
Recommended Comments
There are no comments to display.